Post-Approval Patent Strategy: How to Protect Your Drug from Regulatory and IP Risk After Approval
Post-Approval Isnt DoneIts Where Patent Strategy Gets Real
Most pharma teams treat patent strategy like a pre-approval exercise: file early, win the big battles, and move on. But the reality is harsherand more expensive. The period after approval is wh…
